Dark

LGND
Ligand Pharmaceuticals Inc.
stock NASDAQ

At Close

Feb 26, 2026 3:59:53 PM EST

196.42USD+2.628%(+5.03)256,576

0.00Bid 0.00Ask 0.00Spread

Pre-market

Feb 24, 2026 8:44:30 AM EST

187.00USD-2.294%(-4.39)0

After-hours

Feb 26, 2026 4:00:30 PM EST

196.17USD-0.127%(-0.25)1,986

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

3.77B

CEO

John Higgins

Headquarters

San Diego, California, USA

Industry

Biotechnology

Next Earnings

Feb 26, 2026 (today)

Last Dividend

Apr 3, 20072.500

Last Split

Nov 19, 20101for5.9999reverse

AMGN SPPI GSK BAX BMY JNJ LLY PFE MRK GTXI XLV

LGND Stats

Avg. Vol. 10 Day

162,640

Avg. Vol. 30 Day

221,037

Employees

Market Cap

3,766,884,391

Shares Out.

19,681,720

On/Off Exchange

52%/48%

6 Month Beta

0.56

1 Year Beta

0.83

2 Year Beta

0.95

3 Year Beta

0.98

52 Week Low

93.58

52 Week High

212.49

SMA50

193.68

SMA200

163.73

1 Week

+2.72%

1 Month

-3.45%

3 Month

-7.16%

6 Month

+19.80%

1 Year

+66.41%

2 Year

+157.18%

5 Year

+29.13%

Profile

ligand, a pharmaceutical company, is assembling a large and diverse portfolio of current and near-term commercial revenue generating assets to assist the long-term financial growth of the company. we operate this business on a lean cost structure that allows us to maximize cash flow and ultimately deliver a meaningful return for our shareholders.

LGND Stock Summary

Ligand Pharmaceuticals Inc. (NASDAQ:LGND) stock price today is $196.42, and today's volume is 256,576. LGND is up 2.628% today. The 30 day average volume is 221,037. LGND market cap is 3.77B with 19,681,720 shares outstanding.